Technavio has been monitoring the enzyme-linked immunosorbent assay (Elisa) market and it is poised to grow by USD 124.55 million during 2020-2024, progressing at a CAGR of about 5% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200730005803/en/
Technavio has announced its latest market research report titled Global Enzyme-linked Immunosorbent Assay (Elisa) Market 2020-2024 (Graphic: Business Wire)
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Please Request Free Sample Report on COVID-19 Impact
Frequently Asked Questions-
- At what rate is the market projected to grow during the forecast period 2020-2024?
- Growing at a CAGR of about 5%, the market growth will accelerate during the forecast period.
- What is the key factor driving the market?
- Increasing incidences of cancer is one of the key factors driving the market growth.
- Who are the top players in the market?
- Abbott Laboratories, Abcam Plc, Avantor Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corp., Eppendorf AG, GlaxoSmithKline Plc, Siemens Healthineers AG, and Thermo Fisher Scientific Inc. are some of the major market participants.
- Which region is expected to hold the highest market share?
- APAC
- What is the major trend for enzyme-linked immunosorbent assay (Elisa) market?
- Rising demand for frequent diagnostic testing for the aging population is a major growth factor for the market.
The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Abbott Laboratories, Abcam Plc, Avantor Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corp., Eppendorf AG, GlaxoSmithKline Plc, Siemens Healthineers AG, and Thermo Fisher Scientific Inc. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
Increasing incidences of cancer have been instrumental in driving the growth of the market.
Enzyme-linked Immunosorbent Assay (Elisa) Market 2020-2024: Segmentation
Enzyme-linked Immunosorbent Assay (Elisa) Market is segmented as below:
- End-user
- Hospitals and Diagnostics Center
- Research Laboratories
- Others
- Geographic Landscape
- North America
- APAC
- Europe
- South America
- MEA
To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR41149
Enzyme-linked Immunosorbent Assay (Elisa) Market 2020-2024: Scope
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. Our enzyme-linked immunosorbent assay (Elisa) market report covers the following areas:
- Enzyme-linked Immunosorbent Assay (Elisa) Market size
- Enzyme-linked Immunosorbent Assay (Elisa) Market trends
- Enzyme-linked Immunosorbent Assay (Elisa) Market analysis
This study identifies rising demand for frequent diagnostic testing for the aging population as one of the prime reasons driving the enzyme-linked immunosorbent assay (Elisa) market growth during the next few years.
Enzyme-linked Immunosorbent Assay (Elisa) Market 2020-2024: Vendor Analysis
We provide a detailed analysis of vendors operating in the enzyme-linked immunosorbent assay (Elisa) market, including some of the vendors such as Abbott Laboratories, Abcam Plc, Avantor Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corp., Eppendorf AG, GlaxoSmithKline Plc, Siemens Healthineers AG, and Thermo Fisher Scientific Inc. Backed with competitive intelligence and benchmarking, our research reports on the enzyme-linked immunosorbent assay (Elisa) market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform
Enzyme-linked Immunosorbent Assay (Elisa) Market 2020-2024: Key Highlights
- CAGR of the market during the forecast period 2020-2024
- Detailed information on factors that will assist enzyme-linked immunosorbent assay (Elisa) market growth during the next five years
- Estimation of the enzyme-linked immunosorbent assay (Elisa) market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the enzyme-linked immunosorbent assay (Elisa) market
- Analysis of the market's competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of enzyme-linked immunosorbent assay (Elisa) market vendors
Table of Contents:
Executive Summary
- Market Overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 2024
Five Forces Analysis
- Five Forces Summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by End-user
- Market segments
- Comparison by End-user placement
- Hospitals and diagnostic centers Market size and forecast 2019-2024
- Research laboratories Market size and forecast 2019-2024
- Others Market size and forecast 2019-2024
- Market opportunity by End-user
Customer Landscape
- Overview
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America Market size and forecast 2019-2024
- Europe Market size and forecast 2019-2024
- APAC Market size and forecast 2019-2024
- MEA Market size and forecast 2019-2024
- South America Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
Drivers, Challenges, and Trends
- Market drivers
- Volume driver Demand led growth
- Volume driver Supply led growth
- Volume driver External factors
- Volume driver Demand shift in adjacent markets
- Price driver Inflation
- Price driver Shift from lower to higher priced units
- Market challenges
- Market trends
Vendor Landscape
- Overview
- Vendor landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Abbott Laboratories
- Abcam Plc
- Avantor Inc.
- bioMerieux SA
- Bio-Rad Laboratories Inc.
- Danaher Corp.
- Eppendorf AG
- GlaxoSmithKline Plc
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200730005803/en/
Contacts:
Technavio Research
Jesse Maida
Media Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
